Estrogen receptor beta and ovarian cancer: a key to pathogenesis and response to therapy
@article{Kyriakidis2016EstrogenRB, title={Estrogen receptor beta and ovarian cancer: a key to pathogenesis and response to therapy}, author={Ioannis Kyriakidis and P. Papaioannidou}, journal={Archives of Gynecology and Obstetrics}, year={2016}, volume={293}, pages={1161-1168} }
AbstractIntroduction
Ovarian cancer remains the leading cause of mortality due to gynecological tumors. Estrogen receptors (ERs) seem to participate in tumor progression even in the absence of estrogens. Twenty years after the cloning of the second estrogen receptor, a wide spectrum of studies have shown its implication in both physiologic and pathologic pathways. ERβ, being the predominant type of ER in normal ovary tissue, has not only been linked with pathogenesis of ovarian cancer, but also… CONTINUE READING
Tables and Topics from this paper
Tables
16 Citations
Estrogen Receptor β in Melanoma: From Molecular Insights to Potential Clinical Utility
- Biology, Medicine
- Front. Endocrinol.
- 2016
- 27
- PDF
Feedback control of the CXCR7/CXCL11 chemokine axis by estrogen receptor α in ovarian cancer
- Biology, Medicine
- Molecular oncology
- 2018
- 9
Effect of estrogen receptor β agonists on proliferation and gene expression of ovarian cancer cells
- Biology, Medicine
- BMC Cancer
- 2017
- 22
- PDF
Androgens Are Differentially Associated with Ovarian Cancer Subtypes in the Ovarian Cancer Cohort Consortium.
- Medicine
- Cancer research
- 2017
- 19
- PDF
FRBI suppresses carcinogenesis of uterine cancers by regulating expressions of FHIT, PTEN and ARID1A
- Medicine, Computer Science
- Biomed. Signal Process. Control.
- 2020
The expression of transcription factor BORIS and its association with the estrogen receptor beta (ER-β) in cervical carcinogenesis.
- Biology, Medicine
- International journal of clinical and experimental pathology
- 2019
- 1
- PDF
FSH receptor binding inhibitor restrains follicular development and possibly attenuates carcinogenesis of ovarian cancer through down-regulating expression levels of FSHR and ERβ in normal ovarian tissues.
- Biology, Medicine
- Gene
- 2018
- 8
Endometriosis Malignant Transformation: Epigenetics as a Probable Mechanism in Ovarian Tumorigenesis
- Medicine
- International journal of genomics
- 2018
- 8
- PDF
FSH receptor binding inhibitor restrains ovarian cancer through down-regulating expression levels of FSHR and ERβ in mice
- Biology
- 2018
- 1
- PDF
Overexpression of ARF1 is associated with cell proliferation and migration through PI3K signal pathway in ovarian cancer.
- Biology, Medicine
- Oncology reports
- 2017
- 11
- PDF
References
SHOWING 1-10 OF 78 REFERENCES
Potential Role of Estrogen Receptor Beta as a Tumor Suppressor of Epithelial Ovarian Cancer
- Biology, Medicine
- PloS one
- 2012
- 75
- PDF
Loss of ERbeta expression as a common step in estrogen-dependent tumor progression.
- Biology, Medicine
- Endocrine-related cancer
- 2004
- 419
- PDF
Loss of estrogen receptor beta expression correlates with shorter overall survival and lack of clinical response to chemotherapy in ovarian cancer patients.
- Medicine
- Anticancer research
- 2011
- 36
Estrogen Receptor Subtypes in Ovarian Cancer: A Clinical Correlation
- Medicine
- Obstetrics and gynecology
- 2008
- 98
Sex Steroid Hormone Receptor Expression Affects Ovarian Cancer Survival12
- Medicine
- Translational oncology
- 2015
- 24
- PDF
Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival
- Medicine
- BMC Cancer
- 2012
- 51
- PDF
Mitochondrial estrogen receptor β2 drives antiapoptotic pathways in advanced serous ovarian cancer.
- Biology, Medicine
- Human pathology
- 2015
- 10
Hormone receptors as a marker of poor survival in epithelial ovarian cancer.
- Medicine
- Gynecologic oncology
- 2015
- 41
Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis.
- Medicine
- Cancer letters
- 2006
- 133